Pfizer's stock slightly rose after reporting strong earnings, exceeding analyst expectations.
Pfizer's stock rose 0.2% on Thursday, trading between $24.86 and $24.74. The company recently reported a strong earnings report, with a 24.7% increase in revenue and $0.63 earnings per share, exceeding analyst expectations. Pfizer's market cap is $130.39 billion, with a price-to-earnings ratio of 16.31. Analysts predict a 2.95 EPS for the current year and have given the stock a "Moderate Buy" rating with a target price of $31.92.
5 days ago
14 Articles
Articles
You have 8 free stories remaining this month. Subscribe anytime for unlimited access.